Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties
Molecular Pharmaceutics · 01.07.2024 · 21 (7) · 3471-3484
DOI: 10.1021/acs.molpharmaceut.4c00177 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmaceutics, online erschienen am 13.06.2024. Verfasst von Shoko Takeuchi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Co., Ltd., 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 2518555, Japan. Hauptthemen laut MEDLINE: Aptamers, Nucleotide, Circular Dichroism, Oligonucleotides. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Daiichi-Sankyo, University of Tsukuba, Takeda Pharmaceutical Company.
Abstract (Originalsprache)
Oligonucleotides are short nucleic acids that serve as one of the most promising classes of drug modality. However, attempts to establish a physicochemical evaluation platform of oligonucleotides for acquiring a comprehensive view of their properties have been limited. As the chemical stability and the efficacy as well as the solution properties at a high concentration should be related to their higher-order structure and intra-/intermolecular interactions, their detailed understanding enables effective formulation development. Here, the higher-order structure and the thermodynamic stability of the thrombin-binding aptamer (TBA) and four modified TBAs, which have similar sequences but were expected to have different higher-order structures, were evaluated using ultraviolet spectroscopy (UV), circular dichroism (CD), differential scanning calorimetry (DSC), and nuclear magnetic resonance (NMR). Then, the relationship between the higher-order structure and the solution properties including solubility, viscosity, and stability was investigated. The impact of the higher-order structure on the antithrombin activity was also confirmed. The higher-order structure and intra-/intermolecular interactions of the oligonucleotides were affected by types of buffers because of different potassium concentrations, which are crucial for the formation of the G-quadruplex structure. Consequently, solution properties, such as solubility and viscosity, chemical stability, and antithrombin activity, were also influenced. Each instrumental analysis had a complemental role in investigating the higher-order structure of TBA and modified TBAs. The utility of each physicochemical characterization method during the preclinical developmental stages is also discussed.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Analytical Development, Pharmaceutical Sciences, Takeda Pharmaceutical Co., Ltd., 26-1 Muraoka Higashi 2-Chome, Fujisawa, Kanagawa 2518555, Japan.
- Medical Soft Matter Group, Research Center for Macromolecules and Biomaterials, National Institute for Materials Science, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan.
- Pharmaceutical Developability, CMC Research, Astellas Pharma Inc., 21 Miyukigaoka, Tsukuba, Ibaraki 3058585, Japan.
- Analytical Research, Pharmaceutical Science & Technology Unit, Pharmaceutical Profiling & Development Function, Deep Human Biology Learning, Eisai Co., Ltd., 5-1-3 Tokodai, Tsukuba-shi, Ibaraki 3002635, Japan.
- Pharmacokinetics Group, Biological Research Development, Sawai Pharmaceutical Co., Ltd., 5-2-30 Miyahara, Yodogawa-ku, Osaka 5320003, Japan.
- Formulation Technology Research Laboratories, Pharmaceutical Technology Division, Daiichi Sankyo Co., Ltd., 1-2-58 Hiromachi, Shinagawa-ku, Tokyo 1408710, Japan.
ORCID-Profile: Shoko Takeuchi, Tomohiko Yamazaki, Kohsaku Kawakami
Förderung
- Daiichi-Sankyo
- University of Tsukuba
- Takeda Pharmaceutical Company
- Mitsubishi Tanabe Pharma Corporation
- Astellas Pharma
- National Institute for Materials Science
- Sawai Pharmaceutical
- Materials Open Platform for Pharmaceutical Science
Zitieren
APA
Takeuchi, S., Yamazaki, T., Yamaguchi, K., Komura, F., Tabata, T., Nishi, H., Azumai, S., Miura, K., Hirokawa, M., Ikemoto, K., & Kawakami, K. (2024). Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties. Molecular Pharmaceutics, 21(7), 3471-3484. https://doi.org/10.1021/acs.molpharmaceut.4c00177
Vancouver
Takeuchi S, Yamazaki T, Yamaguchi K, Komura F, Tabata T, Nishi H, et al. Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties. Molecular Pharmaceutics. 2024;21(7):3471-3484. doi:10.1021/acs.molpharmaceut.4c00177
BibTeX
@article{Takeuchi2024,
author = {Takeuchi, Shoko and Yamazaki, Tomohiko and Yamaguchi, Katsutoshi and Komura, Fusae and Tabata, Takahiro and Nishi, Hirotaka and Azumai, Satomi and Miura, Kanako and Hirokawa, Mai and Ikemoto, Keisuke and Kawakami, Kohsaku},
title = {Toward the Establishment of a Harmonized Physicochemical Profiling Platform for Therapeutic Oligonucleotides: A Case Study for Aptamers Where the Higher-Order Structure Influences Physical Properties},
journal = {Molecular Pharmaceutics},
year = {2024},
volume = {21},
number = {7},
pages = {3471--3484},
doi = {10.1021/acs.molpharmaceut.4c00177}
}
EUVIMED